Apella Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Apella Capital's AMGN Position: Q2 2026 in Review
Apella Capital reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $14K and leaving 2,984 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #357.
Apella Capital first reported a position in AMGN in Q1 2020 and has held it in 22 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Apella Capital held 2,984 shares of Amgen worth $1.1M as of Q2 2026.
- Apella Capital sold 41 Amgen shares in Q2 2026, an estimated $14K.
- Amgen made up 0.02% of Apella Capital's portfolio in Q2 2026, its #357 holding.
- Apella Capital first reported a position in Amgen in Q1 2020 and has held it in 22 quarters since.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.